News

Categories
Sign up
Featured Posts
Archive
Follow Us
  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon

Newsletter - Issue no. 2

We are delighted to share with you our first quarterly newsletter of 2019. Beyond the great operational progress, our most important advancement this quarter has been the highly promising clinical results from the cancer centers, Rabin Medical Center (RMC) in Israel and IRST in Italy. In 26 patients treated at RMC and 5 patients at IRST, over 70% of the tumors were entirely destroyed. Patients also showed no negative systemic side effects and minimal local toxicity when compared to surgery or radiotherapy. Alongside our ongoing squamous cell carcinoma (SCC) trial, we have recently launched a new clinical trial to treat all types of skin and oral cavity cancer at RMC. We are thrilled that

Alpha Tau

Looking for clinical trials?

  • Grey Facebook Icon
  • Grey LinkedIn Icon
  • Grey Twitter Icon